Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals. [electronic resource]
Producer: 20140802Description: 287-94 p. digitalISSN:- 1365-2249
- Abatacept
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- complications
- Biological Therapy
- Cytokines -- metabolism
- Female
- Follow-Up Studies
- Humans
- Immunoconjugates -- administration & dosage
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- complications
- Italy
- Male
- Middle Aged
- Pandemics
- Polysorbates -- administration & dosage
- Seasons
- Squalene -- administration & dosage
- T-Lymphocytes -- drug effects
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.